Latest Breaking News On - Professor gerhardt attard - Page 1 : comparemela.com

Johnson & Johnson : Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorization for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

BEERSE, Belgium, 21 April 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission has granted marketing authorisation for AKEEGA®. | April 21, 2023

Region flamandeUnited kingdomCity ofJanssen cilag gmbMartin vogelMagda palhotaPeter lebowitzGerhardt attardJanssen cilag gmUrology care foundationExchange commissionDrug administrationCompanies of johnsonJanssen research developmentEuropean medicines agencyUniversity college london

Johnson & Johnson : Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

News Release Media Enquiries: Magda Palhota Phone: +351 91 2799282 Email: mpalhota@its.jnj.com . | April 21, 2023

United kingdomRegion flamandeCity ofJanssen cilag gmbPeter lebowitzMartin vogelMagda palhotaGerhardt attardEuropean commissionUniversity college londonCompanies of johnsonJanssen cilag internationalEuropean unionDrug administrationJanssen biotech incTesaro inc

Agilent Announces Thought Leader Award to Gerhardt Attard at University College London (UCL)

Agilent Announces Thought Leader Award to Gerhardt Attard at University College London (UCL)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomRonda allenAngharad milenkovicGerhardt attardNaomi goumilloutAgilent technologies incJohn black charitable foundationGenomics group at agilentUrological cancer research at university college londonCancer instituteCancer research united kingdom clinician scientistAgilent technologiesTeam leader of the treatment resistance groupProfessor gerhardt attardAgilent thought leaderProf attard

Prostate cancer drugs that halve risk of dying

Prostate cancer drugs that halve risk of dying
dailytrust.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailytrust.com Daily Mail and Mail on Sunday newspapers.

United kingdomNick jamesGerhardt attardUniversity college londonNational institute for healthInstitute of cancer researchNational instituteCare excellenceProfessor gerhardt attardCancer researchRoyal marsden

Prostate cancer drugs that halve risk of dying: New hope for patients thanks to new treatment

Prostate cancer drugs that halve risk of dying: New hope for patients thanks to new treatment
dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofKotryna temcinaiteNick jamesGerhardt attardUniversity college londonNational institute for healthEuropean society for medical oncology congressInstitute of cancer researchCancer research united kingdomMd anderson cancer centreUniversity of texasNational instituteCare excellenceProfessor gerhardt attardCancer research